From the Journals

Axial SpA features don’t guarantee its diagnosis in chronic back pain


 

FROM ANNALS OF THE RHEUMATIC DISEASES

The manifestation of multiple features of spondyloarthritis (SpA) in patients with chronic back pain is not sufficient for a diagnosis of axial spondyloarthritis, according to a report from Zineb Ez-Zaitouni and associates.

In a group of 250 people with chronic back pain who were not diagnosed with axial SpA, the most common alternative diagnosis was nonspecific back pain, followed by mechanical back pain, degenerative disc disease, and myalgia/fibromyalgia. Sacroiliitis on either radiographs or MRI and HLA-B27 was uncommon, and HLA-B27 positivity was also infrequent.

A total of 18 patients within the study group had at least four features of SpA but did not have axial SpA. Within this group, the most common SpA features were inflammatory back pain, a positive family history of SpA, a good response to nonsteroidal anti-inflammatory drugs, elevated C-reactive protein or erythrocyte sedimentation rate, and enthesitis. No patients had positive imaging, and only four were positive for HLA-B27.

“These findings show that rheumatologists in clinical practice rightly dispute a diagnosis of axSpA even when there is a high number of SpA features, especially when imaging is normal and patients are negative for HLA-B27,” the investigators concluded.

Find the full report in Annals of the Rheumatic Diseases (doi: 10.1136/annrheumdis-2017-212175)

Recommended Reading

EMEUNET tailors EULAR experience for young rheumatologists
MDedge Rheumatology
EULAR program features novel treatments and targets in immune pathways and key overviews of the field
MDedge Rheumatology
Sacroiliac structural changes show on MRI in nonradiographic axial SpA despite no inflammation
MDedge Rheumatology
VIDEO: Rheumatology biosimilars gain U.S. momentum
MDedge Rheumatology
Panel revises spondyloarthritis treat-to-target recommendations
MDedge Rheumatology
Obesity blunts TNFi response in axial spondyloarthritis
MDedge Rheumatology
TNFi treatment halves ankylosing spondylitis progression
MDedge Rheumatology
CT scoring system may improve sacroiliitis treatment in IBD
MDedge Rheumatology
First interchangeability study for an adalimumab biosimilar has begun
MDedge Rheumatology
Radiographic progression in axial spondyloarthritis moves slowly in first 5 years
MDedge Rheumatology